Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member., inc. (CRM) Makes a Doubtful Purchase

Page 1 of 2

Not long ago I wrote, inc. (NYSE:CRM) is overvalued., inc. (NYSE:CRM) has now told the world it is acquiring marketing firm ExactTarget Inc (NYSE:ET) for $33.75 per share in cash. The total transaction value would be approximately $2.5 billion. This represents a 53% premium to the price at which ExactTarget Inc (NYSE:ET) traded the day before the announcement., inc. (NYSE:CRM)

The race

According to Gartner, is the leading customer relationship management, or CRM, system in the world — hence its ticker symbol. Besides its main platform,, inc. (NYSE:CRM) offers Sales Cloud, Service Cloud and Marketing Cloud. It is the Marketing Cloud that thought needed to be strengthened. This is the rationale behind the purchase.

In late 2012, Oracle Corporation (NASDAQ:ORCL) purchased cloud marketing software provider Eloqua for $871 million. Oracle is one of the main players in the field and has been paying its way into the market with purchases, as it got into CRM by buying PeopleSoft and Siebel.

Other big players in the market, such as Microsoft Corporation (NASDAQ:MSFT) and SAP AG (ADR) (NYSE:SAP) are expected to make moves as well. Microsoft is trying to push its Microsoft Corporation (NASDAQ:MSFT) Dynamics to a higher market share. Currently, its product focuses on smaller customers than those of Oracle and SAP AG (ADR) (NYSE:SAP).

SAP AG (ADR) (NYSE:SAP) is always a player to consider. A leading Enterprise Research Planning, or ERP provider, it has a huge customer base, which allows it to cross-sell its solutions.

There is big difference between, inc. (NYSE:CRM) and giants like Oracle, Microsoft Corporation (NASDAQ:MSFT) and SAP. They can afford to acquire new technology without harming their stocks., which trades at a forward earnings multiple of 60, does not have this luxury. Microsoft and Oracle Corporation (NASDAQ:ORCL) trade at multiples of 11.43 times forward earnings and 11.70, respectively. SAP is pricier, trading at 19 times forward earnings. The purchase would make sense for shareholders if it would significantly improve its revenue prospects, but would it?

The future finished the first quarter with approximately $3.1 billion in cash and marketable securities. The firm has stated that it plans to finance the transaction with the help of both cash and a term loan., inc. (NYSE:CRM) is already highly leveraged with a 0.69 debt-to-equity ratio.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!